These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9952325)

  • 1. Effects of inhaled dry powder ipratropium bromide on recovery from exercise of horses with COPD.
    Duvivier DH; Bayly WM; Votion D; Vandenput S; Art T; Farnir F; Lekeux P
    Equine Vet J; 1999 Jan; 31(1):20-4. PubMed ID: 9952325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway response of horses with COPD to dry powder inhalation of ipratropium bromide.
    Duvivier DH; Votion D; Vandenput S; Art T; Lekeux P
    Vet J; 1997 Sep; 154(2):149-53. PubMed ID: 9308401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inhaled ipratropium bromide on breathing mechanics and gas exchange in exercising horses with chronic obstructive pulmonary disease.
    Bayly WM; Duvivier DH; Votion D; Vandenput S; Art T; Lekeux P
    Equine Vet J; 2002 Jan; 34(1):36-43. PubMed ID: 11817550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical validation of a face mask adapted for dry powder inhalation in the equine species.
    Duvivier DH; Votion D; Vandenput S; Art T; Lekeux P
    Equine Vet J; 1997 Nov; 29(6):471-6. PubMed ID: 9413721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does an acute COPD crisis modify the cardiorespiratory and ventilatory adjustments to exercise in horses?
    Art T; Duvivier DH; Votion D; Anciaux N; Vandenput S; Bayly WM; Lekeux P
    J Appl Physiol (1985); 1998 Mar; 84(3):845-52. PubMed ID: 9480942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energetic cost of breathing, body composition, and pulmonary function in horses with recurrent airway obstruction.
    Mazan MR; Deveney EF; DeWitt S; Bedenice D; Hoffman A
    J Appl Physiol (1985); 2004 Jul; 97(1):91-7. PubMed ID: 14966015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
    Pillet O; Manier G; Castaing Y
    Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of salmeterol and ipratropium bromide on exercise performance and breathlessness in patients with stable chronic obstructive pulmonary disease.
    Patakas D; Andreadis D; Mavrofridis E; Argyropoulou P
    Respir Med; 1998 Sep; 92(9):1116-21. PubMed ID: 9926165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
    Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T
    Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of inhaled beclomethasone dipropionate on respiratory function in horses with chronic obstructive pulmonary disease (COPD).
    Ammann VJ; Vrins AA; Lavoie JP
    Equine Vet J; 1998 Mar; 30(2):152-7. PubMed ID: 9535072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients?
    Akkoca Yildiz O; Onen ZP; Demir G; Eriş Gülbay B; Saryal S; Karabiyikoğlu G
    Tuberk Toraks; 2006; 54(2):105-13. PubMed ID: 16924565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease.
    Rammeloo RH; Luursema PB; Sips AP; Beumer HM; Wald FD; Cornelissen PJ
    Respiration; 1992; 59(6):322-6. PubMed ID: 1488568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
    Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
    Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonbronchodilator effects of pirbuterol and ipratropium in chronic obstructive pulmonary disease.
    Ashutosh K; Dev G; Steele D
    Chest; 1995 Jan; 107(1):173-8. PubMed ID: 7813271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of high-dose ipratropium bromide and oral aminophylline on spirometry and exercise tolerance in COPD.
    Shivaram U; Cash ME; Mateo F; Shim C
    Respir Med; 1997 Jul; 91(6):327-34. PubMed ID: 9282234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchodilator activity of the selective muscarinic antagonist revatropate in horses with heaves.
    McGorum BC; Nicholas DR; Foster AP; Shaw DJ; Pirie RS
    Vet J; 2013 Jan; 195(1):80-5. PubMed ID: 22850354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
    Friedman M
    Am J Med; 1996 Jan; 100(1A):30S-39S. PubMed ID: 8610715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD.
    Martin RJ; Bartelson BL; Smith P; Hudgel DW; Lewis D; Pohl G; Koker P; Souhrada JF
    Chest; 1999 May; 115(5):1338-45. PubMed ID: 10334150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.